← FDA ENFORCEMENT
D-0434-2024Class III

X-Gen Pharmaceuticals Inc.

Recalling firm
X-Gen Pharmaceuticals Inc.
Product type
Drug
Status
Terminated
Report date
2024-04-10
Distribution
Nationwide in the US
Firm state
NY
Product quantity
1332 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Documentation & Change Control
Reason for recall

Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

Product description

Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.

Code / lot info

Lot #: CIC2-23001 A, Exp. 11/30/2026

Other recalls SPEQ maps to Documentation & Change Control
2026-07-22Class IIDaavlin Distributing Company2026-07-22Class IIOrthofix U.S. LLC2026-07-22Class II3B Medical, Inc.2026-07-22Class IIDaavlin Distributing Company
See all Documentation & Change Control recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.